LeadIQ logo
Learn more at LeadIQ.com

Insights

Cutting-Edge Gamma-Delta T Cell Therapies Adicet Bio is a leading biotechnology company specializing in innovative gamma-delta T cell therapies for autoimmune diseases and cancer. This cutting-edge technology presents a unique selling point for engaging with healthcare providers and institutions seeking advanced treatment options for patients.

Expansion to Boston Market With a presence in both Redwood City, CA, and Boston, MA, Adicet Bio's expansion into the Boston market provides a strategic opportunity to tap into the vibrant biotech ecosystem in the region. Leveraging this expansion, sales professionals can explore partnerships with local research institutions and biopharma companies looking for collaboration opportunities.

Successful Launch of ADI-270 The successful launch of ADI-270, a novel CAR T-cell therapy targeting CD70-expressing tumors, opens doors for sales professionals to engage with oncology specialists and treatment centers interested in adopting cutting-edge therapies for cancer patients. Highlighting the unique benefits and clinical data of ADI-270 can drive interest and adoption in the oncology market.

Attracting Top Talent and Key Personnel Adicet Bio's ability to attract top industry talent like Lloyd Klickstein and Katie Peng to its Board of Directors underscores its credibility and expertise in the biotechnology space. Leveraging the reputations and networks of these key personnel can enhance sales outreach efforts by establishing credibility and building relationships with key stakeholders in the industry.

Strategic Funding and Financial Stability With significant funding and revenue in the range of $10M-$50M, Adicet Bio exhibits financial stability and growth potential. Sales professionals can leverage this information to instill confidence in potential investors, collaborators, and customers, showcasing the company's long-term viability and sustainability in the competitive biotechnology landscape.

Similar companies to Adicet Bio, Inc

Adicet Bio, Inc Tech Stack

Adicet Bio, Inc uses 8 technology products and services including SAS, Drupal, Open Graph, and more. Explore Adicet Bio, Inc's tech stack below.

  • SAS
    Business Intelligence
  • Drupal
    Content Management System
  • Open Graph
    Miscellaneous
  • C++
    Programming Languages
  • HSTS
    Security
  • Adobe Tag Manager
    Tag Management
  • Apache
    Web Servers
  • Facebook
    Widgets

Media & News

Adicet Bio, Inc's Email Address Formats

Adicet Bio, Inc uses at least 1 format(s):
Adicet Bio, Inc Email FormatsExamplePercentage
FLast@adicetbio.comJDoe@adicetbio.com
91%
FirstLast@adicetbio.comJohnDoe@adicetbio.com
5%
Last_First@adicetbio.comDoe_John@adicetbio.com
3%
Last.First@adicetbio.comDoe.John@adicetbio.com
1%

Frequently Asked Questions

Where is Adicet Bio, Inc's headquarters located?

Minus sign iconPlus sign icon
Adicet Bio, Inc's main headquarters is located at 1000 Bridge Pkwy Redwood City, California 94065 US. The company has employees across 3 continents, including North AmericaAsiaAfrica.

What is Adicet Bio, Inc's phone number?

Minus sign iconPlus sign icon
You can contact Adicet Bio, Inc's main corporate office by phone at . For more prospecting data, LeadIQ has access to up-to-date and accurate contact information within our platform. Find, capture, and sync contact data to your CRM and sales tools in one click.

What is Adicet Bio, Inc's stock symbol?

Minus sign iconPlus sign icon
Adicet Bio, Inc is a publicly traded company; the company's stock symbol is ACET.

What is Adicet Bio, Inc's official website and social media links?

Minus sign iconPlus sign icon
Adicet Bio, Inc's official website is adicetbio.com and has social profiles on LinkedIn.

How much revenue does Adicet Bio, Inc generate?

Minus sign iconPlus sign icon
As of October 2024, Adicet Bio, Inc's annual revenue reached $35M.

What is Adicet Bio, Inc's SIC code NAICS code?

Minus sign iconPlus sign icon
Adicet Bio, Inc's SIC code is 2834 - Pharmaceutical Preparations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Adicet Bio, Inc have currently?

Minus sign iconPlus sign icon
As of October 2024, Adicet Bio, Inc has approximately 157 employees across 3 continents, including North AmericaAsiaAfrica. Key team members include Chief Regulatory Officer: N. B.Chief Scientific Officer: B. A.Chief Technology Officer: D. H.. Explore Adicet Bio, Inc's employee directory with LeadIQ.

What industry does Adicet Bio, Inc belong to?

Minus sign iconPlus sign icon
Adicet Bio, Inc operates in the Biotechnology Research industry.

What technology does Adicet Bio, Inc use?

Minus sign iconPlus sign icon
Adicet Bio, Inc's tech stack includes SASDrupalOpen GraphC++HSTSAdobe Tag ManagerApacheFacebook.

What is Adicet Bio, Inc's email format?

Minus sign iconPlus sign icon
Adicet Bio, Inc's email format typically follows the pattern of . Find more Adicet Bio, Inc email formats with LeadIQ.

How much funding has Adicet Bio, Inc raised to date?

Minus sign iconPlus sign icon
As of October 2024, Adicet Bio, Inc has raised $98M in funding. The last funding round occurred on Jan 22, 2024 for $98M.
Adicet Bio, Inc

Adicet Bio, Inc

Biotechnology ResearchCalifornia, United States51-200 Employees

At Adicet (Nasdaq: ACET), we are defined by our mission to deliver best-in-class gamma-delta T cell therapies for patients fighting autoimmune diseases and cancer. Every one of our team members, whether in the lab, manufacturing, or general business role, comes to work every day with the patient in mind. 

As pioneers in the cell therapy space, we are honored and humbled by the opportunity to put our talents to bear in developing transformative therapies to defeat autoimmune diseases and cancer. We believe that the best way to do this is through discovering and developing allogeneic gamma-delta T cell therapies, a novel type of cell therapy.

Adicet has chosen the gamma-delta T cell because it:
•	Preferentially traffics to tissues and provides B cell depletion, potentially leading to an immune reset for patients with autoimmune diseases.
•	Has multiple ways to target and kill cancer cells including solid tumors. 

We also chose to use cells from donors (allogeneic) to enable our potential therapies to be readily available when needed (taken “off-the-shelf” or available to the patient on demand). 

We’re not just blazing new trails in cell therapy, we’re having fun along the way. With regular team gatherings, many shared meals, larger company events, and a consistent commitment to our values, we have a strong culture! 

We are proud to attract and retain some of the greatest talent in the biopharma and cell therapy space, and we’re consistently giving back to our employees. The Adicet benefits package includes generous financial compensation, comprehensive health plans, generous paid time-off, educational reimbursement, and access to many amenities in our state-of-the-art facility. 

To learn more or inquire about joining our team in Boston, MA or Redwood City, CA, please visit http://www.adicetbio.com

Section iconCompany Overview

Headquarters
1000 Bridge Pkwy Redwood City, California 94065 US
Phone number
SIC Code
2834 - Pharmaceutical Preparations
Stock Symbol
ACET
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Employees
51-200

Section iconMedia & News

Section iconFunding & Financials

  • $98M

    Adicet Bio, Inc has raised a total of $98M of funding over 5 rounds. Their latest funding round was raised on Jan 22, 2024 in the amount of $98M.

  • $10M$50M

    Adicet Bio, Inc's revenue is in the range of $10M$50M

Section iconFunding & Financials

  • $98M

    Adicet Bio, Inc has raised a total of $98M of funding over 5 rounds. Their latest funding round was raised on Jan 22, 2024 in the amount of $98M.

  • $10M$50M

    Adicet Bio, Inc's revenue is in the range of $10M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.